Hold, Drop, or Push Through: The Dose Decision Nobody Explains

The thing to know first

Asking to hold your dose is written into the label. Not a concession, not failing — the prescribing information says it in as many words: if a patient does not tolerate a dose during escalation, consider delaying dosage escalation for 4 weeks¹.

That sentence is worth screenshotting, because a lot of women are made to feel that a step-up is a schedule they have to keep.

The ladders you are actually on

Three details people miss.

Wegovy has two labelled maintenance doses, not one. 1.7 mg or 2.4 mg — 2.4 is the recommended one, but 1.7 mg is a licensed place to stay, not a failed attempt at 2.4¹.

Both labels say to consider response and tolerability when choosing the maintenance dose, in those words. This is not a tirzepatide-only feature. The top of the ladder is a maximum, not a destination¹².

*Zepbound's increase comes after at least* four weeks — a floor, not a deadline. But note its 2.5 mg starting dose is for initiation and is not approved as a maintenance dosage**, so that is not a rung you can settle on².

The three options, and when each fits

• Push through. For symptoms that are unpleasant but stable or easing, and where nothing about the week is high-stakes. Most first-week nausea belongs here.
• Hold at your current dose. For symptoms that are not settling by the end of a cycle, or when the next four weeks contain something you cannot be unwell for. This is the label's own suggestion and the most under-used option.
• Step back down. For symptoms that are affecting whether you can eat, drink, work or drive. A dose you cannot function on is not a dose you are on.

Holding is not the same as stopping, and neither is a restart from scratch.

One distinction worth being precise about, because people conflate them: holding means continuing to inject your current dose on schedule. It does not mean skipping shots. If you actually miss two or more consecutive doses, Wegovy's label says escalation may need to reinitiate at a lower dosage to keep gut side effects manageable¹ — a different situation with a different answer.

What to say

Scripts, because the ask is easier with words ready:

• "I'd like to hold at this dose for another four weeks before stepping up."
• "This dose is affecting my ability to work. Can we go back to the previous one?"
• "I have something I can't be unwell for in three weeks. Can the increase wait until after?"

A programme that treats any of these as non-compliance is telling you something useful about itself.

★ Where this stops being a dose decision

Some things are not titration problems. Same-day contact if you:

• cannot keep fluids down, or are passing much less urine than usual
• have severe or persistent abdominal pain, especially upper-right or radiating to your back
• are vomiting food eaten many hours earlier
• have yellowing of the eyes or skin
• feel faint or dizzy on standing

Do not "hold and see" through any of those. They are separate questions from whether the dose suits you.

Two practical notes

Do not stack changes. Changing dose in the same week as starting another medication makes it impossible to tell what caused what.

Write down your dose and injection day. If you do call, those are the first two things you will be asked, and nobody remembers under pressure.

If you take one thing from this: the ladder in the label is a recommendation with a hold built into it, not a timetable you are behind on.